Duration 7:6

OPZELURA ( Ruxolitinib ), finally a cure for VITILIGO

by Fedy
37 708 watched
0
480
Published 7 Aug 2022

Book your 1-on-1 meeting with me: https://calendly.com/actuallycurious/30min You can support my channel here: https://www.buymeacoffee.com/fedy Today's video is about Ruxolitinib, a new drug approved by the FDA for the treatment of non segmental vitiligo. In this video u will be able to differenciate whether u have segmental or non segmental vitiligo. Also i discussed the inclusion criteria used by the authors in the study so by the end of the video u will know if u qualify for the this new treatment. I also discussed the outcomes, and side effects of the drug found in the 2 phase 3 clinical trials TRUE V1 and TRUE V2. I'm slowly developing my editing skills so even a like would motivate me to improve in my next videos :') Vitiligo in India: /watch/suS4GDxHb52H4 DATA : - FDA approval: https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-topical-treatment-addressing-repigmentation-vitiligo-patients-aged-12-and-older - Outcomes presented in American Academy of Dermatology Annual Meeting : https://www.ajmc.com/view/ruxolitinib-cream-shows-improved-efficacy-sustained-safety-in-vitiligo-after-extended-follow-up Timecodes 0:00 - Intro 0:25 - Segmental and non segmental vitiligo 3:35 - Do you qualify ? 4:20 - Study outcomes 5:45 - Side effects

Category

Show more

Comments - 174